A detailed history of Patten & Patten Inc transactions in Amgen Inc stock. As of the latest transaction made, Patten & Patten Inc holds 2,947 shares of AMGN stock, worth $774,029. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,947
Previous 3,006 1.96%
Holding current value
$774,029
Previous $939,000 1.06%
% of portfolio
0.07%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$309.38 - $337.38 $18,253 - $19,905
-59 Reduced 1.96%
2,947 $949,000
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $25,749 - $31,292
-98 Reduced 3.16%
3,006 $939,000
Q1 2024

May 10, 2024

BUY
$268.87 - $324.56 $36,566 - $44,140
136 Added 4.58%
3,104 $882,000
Q4 2023

Jan 23, 2024

BUY
$255.7 - $288.46 $34,008 - $38,365
133 Added 4.69%
2,968 $854,000
Q3 2023

Oct 27, 2023

SELL
$218.65 - $271.46 $43,292 - $53,749
-198 Reduced 6.53%
2,835 $761,000
Q2 2023

Jul 14, 2023

SELL
$214.27 - $253.37 $70,280 - $83,105
-328 Reduced 9.76%
3,033 $673,000
Q1 2023

Apr 25, 2023

SELL
$225.79 - $275.2 $10,837 - $13,209
-48 Reduced 1.41%
3,361 $812,000
Q4 2022

Feb 01, 2023

SELL
$229.03 - $291.01 $68,250 - $86,720
-298 Reduced 8.04%
3,409 $895,000
Q3 2022

Oct 19, 2022

SELL
$224.46 - $253.15 $1,795 - $2,025
-8 Reduced 0.22%
3,707 $836,000
Q2 2022

Aug 02, 2022

SELL
$230.71 - $256.74 $51,448 - $57,253
-223 Reduced 5.66%
3,715 $904,000
Q1 2022

Apr 25, 2022

SELL
$219.27 - $242.57 $3,508 - $3,881
-16 Reduced 0.4%
3,938 $952,000
Q4 2021

Jan 26, 2022

BUY
$198.88 - $227.6 $3,977 - $4,552
20 Added 0.51%
3,954 $890,000
Q3 2021

Oct 22, 2021

SELL
$212.27 - $248.7 $134,154 - $157,178
-632 Reduced 13.84%
3,934 $837,000
Q2 2021

Jul 13, 2021

BUY
$233.58 - $259.14 $208,586 - $231,412
893 Added 24.31%
4,566 $1.11 Million
Q1 2021

Apr 23, 2021

BUY
$221.91 - $258.6 $29,957 - $34,911
135 Added 3.82%
3,673 $914,000
Q4 2020

Jan 19, 2021

BUY
$216.38 - $257.67 $43,492 - $51,791
201 Added 6.02%
3,538 $814,000
Q3 2020

Oct 08, 2020

SELL
$234.65 - $260.95 $22,995 - $25,573
-98 Reduced 2.85%
3,337 $848,000
Q2 2020

Jul 21, 2020

BUY
$197.81 - $242.74 $32,440 - $39,809
164 Added 5.01%
3,435 $810,000
Q1 2020

Apr 16, 2020

SELL
$182.24 - $241.7 $60,503 - $80,244
-332 Reduced 9.21%
3,271 $663,000
Q4 2019

Jan 13, 2020

BUY
$189.21 - $243.2 $103,308 - $132,787
546 Added 17.86%
3,603 $868,000
Q3 2019

Oct 15, 2019

BUY
$174.11 - $208.62 $124,662 - $149,371
716 Added 30.59%
3,057 $592,000
Q2 2019

Jul 11, 2019

SELL
$166.7 - $195.41 $41,008 - $48,070
-246 Reduced 9.51%
2,341 $431,000
Q1 2019

Apr 23, 2019

BUY
$180.87 - $203.88 $9,043 - $10,194
50 Added 1.97%
2,587 $491,000
Q4 2018

Jan 17, 2019

SELL
$178.4 - $208.25 $41,745 - $48,730
-234 Reduced 8.44%
2,537 $494,000
Q3 2018

Oct 17, 2018

SELL
$185.29 - $208.89 $13,526 - $15,248
-73 Reduced 2.57%
2,771 $574,000
Q2 2018

Jul 18, 2018

BUY
$166.05 - $186.51 $332 - $373
2 Added 0.07%
2,844 $525,000
Q1 2018

Apr 20, 2018

SELL
$169.43 - $198.0 $33,716 - $39,402
-199 Reduced 6.54%
2,842 $485,000
Q4 2017

Jan 22, 2018

SELL
$168.79 - $188.59 $16,710 - $18,670
-99 Reduced 3.15%
3,041 $529,000
Q3 2017

Oct 12, 2017

BUY
$167.29 - $191.0 $525,290 - $599,740
3,140
3,140 $585,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Patten & Patten Inc Portfolio

Follow Patten & Patten Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten & Patten Inc, based on Form 13F filings with the SEC.

News

Stay updated on Patten & Patten Inc with notifications on news.